CIK: 0001595855
申告総資産額
$7.6億
| # | ティッカー | 発行体 | 資産子分類 | 比率 | 比率変動 | 持株数変化 | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | 2655787D | Blueprint Medicines CORP | 株式-その他 | 12.20% | — | -5.99% | |
| 2 | AXGN | Axogen INC | 株式-その他 | 9.45% | — | +700.00% | |
| 3 | ✓ | Ariad Pharmaceuticals INC | 株式-その他 | 7.49% | — | +207.35% | |
| 4 | ✓ | Medgenics Inc New | 株式-その他 | 5.25% | — | +592.31% | |
| 5 | AGIO | Agios Pharmaceuticals INC | 株式-その他 | 3.59% | — | -92.61% | |
| 6 | FGENEUR | Fibrogen INC | 株式-その他 | 3.57% | — | +117.11% | |
| 7 | ✓ | Foamix Pharmaceuticals LTD | 株式-その他 | 3.05% | — | +215.00% | |
| 8 | CARAEUR | Cara Therapeutics INC | 株式-その他 | 2.95% | — | — | |
| 9 | CDXS | Codexis INC | 株式-その他 | 2.72% | — | +225.00% | |
| 10 | CTH | Cynapsus Therapeutics INC | 株式-その他 | 2.63% | — | -21.88% | |
| 11 | ✓ | Horizon Pharma PLC | 株式-その他 | 2.61% | — | — | |
| 12 | EGRX | Eagle Pharmaceuticals INC | 株式-その他 | 2.56% | — | -46.15% | |
| 13 | ✓ | Imprimis Pharma Immy | 株式-その他 | 2.42% | — | +358.63% | |
| 14 | GBTUSD | Global Blood Therapeutics In | 株式-その他 | 2.41% | — | — | |
| 15 | PLX 4.5 09-15-18 | Protalix Biotherapeautic | 株式-その他 | 2.41% | — | +7585.71% | |
| 16 | MGNX | Macrogenics INC | 株式-その他 | 2.27% | — | — | |
| 17 | CMRXEUR | Chimerix INC | 株式-その他 | 2.26% | — | -33.81% | |
| 18 | ✓ | Aquinox Pharmaceuticals INC Bc | 株式-その他 | 2.17% | — | — | |
| 19 | ADMSEUR | Adamas Pharmaceuticals INC | 株式-その他 | 2.15% | — | -57.98% | |
| 20 | IMMU | Immunomedics INC | 株式-その他 | 2.04% | — | -5.33% | |
| 21 | RCKT 5 02-15-20 | Rocket Pharmaceuticals | 株式-その他 | 1.98% | — | -37.98% | |
| 22 | XENE | Xenon Pharmaceuticals INC | 株式-その他 | 1.74% | — | — | |
| 23 | PRTA | Prothena Corporation plc | 株式-その他 | 1.57% | — | — | |
| 24 | EWTX | Edgewise Therapeutics, Inc. | 株式-その他 | 1.53% | — | -15.15% | |
| 25 | ✓ | Loxo Oncology INC | 株式-その他 | 1.51% | — | — | |
| 26 | TREUR | Trillium Therapeutics INC | 株式-その他 | 1.35% | — | -10.26% | |
| 27 | ✓ | Zogenix INC | 株式-その他 | 1.32% | — | — | |
| 28 | CTMX | Cytomx Therapeutics INC | 株式-その他 | 1.31% | — | — | |
| 29 | RARE | Ultragenyx Pharmaceutical In | 株式-その他 | 1.30% | — | -46.15% | |
| 30 | PTIEUR | Proteostasis Therapeutics In | 株式-その他 | 1.24% | — | — | |
| 31 | LION | Lionsgate Studios Corp. | 株式-その他 | 1.21% | — | — | |
| 32 | ✓ | Corium Intl INC | 株式-その他 | 1.18% | — | +220.00% | |
| 33 | ✓ | Amarin Corp PLC | 株式-その他 | 1.17% | — | -44.00% | |
| 34 | ✓ | Neuroderm LTD | 株式-その他 | 0.95% | — | +87.62% | |
| 35 | ✓ | Nabriva Therapeutics AG | 株式-その他 | 0.88% | — | -87.72% | |
| 36 | ✓ | Innocoll Hldgs PLC | 株式-その他 | 0.82% | — | — | |
| 37 | AFRM | Affirm Holdings, Inc. | 株式-金融 | 0.63% | — | +258.33% | |
| 38 | ✓ | Intec Pharma LTD Jerusalem | 株式-その他 | 0.54% | — | -73.08% | |
| 39 | ✓ | Tenax Therapeutics INC | 株式-その他 | 0.47% | — | +122.86% | |
| 40 | ✓ | Portola Pharmaceuticals INC | 株式-その他 | 0.42% | — | — | |
| 41 | ABEO1EUR | Abeona Therapeutics INC | 株式-その他 | 0.31% | — | — | |
| 42 | AMAG | Amag Pharmaceuticals INC | 株式-その他 | 0.19% | — | -94.92% | |
| 43 | ✓ | Biolinerx Ltd-spons Adr | 株式-その他 | 0.15% | — | — | |
| 44 | ✓ | Depomed INC | 株式-その他 | 0.02% | — | -99.27% |
| # | ティッカー | 発行体 | 比率変動 | 持株数変化 | アクション |
|---|---|---|---|---|---|
| 1 | 2655787D | Blueprint Medicines CORP | +9.5% | -5.99% | 減少 |
| 2 | AXGN | Axogen INC | +9.3% | +700.00% | 増加 |
| 3 | ✓ | Ariad Pharmaceuticals INC | +6.5% | +207.35% | 増加 |
| 4 | ✓ | Medgenics Inc New | +3.8% | +592.31% | 増加 |
| 5 | EGRX | Eagle Pharmaceuticals INC | +2% | -46.15% | 減少 |
| 6 | FGENEUR | Fibrogen INC | +1.9% | +117.11% | 増加 |
| 7 | CDXS | Codexis INC | +1.9% | +225.00% | 増加 |
| 8 | PLX 4.5 09-15-18 | Protalix Biotherapeautic | +1.6% | +7585.71% | 増加 |
| 9 | CTH | Cynapsus Therapeutics INC | +1.5% | -21.88% | 減少 |
| 10 | ✓ | Imprimis Pharma Immy | +1.4% | +358.63% | 増加 |
| 11 | CARAEUR | Cara Therapeutics INC | +1.2% | — | 変化なし |
| 12 | ADMSEUR | Adamas Pharmaceuticals INC | +1.2% | -57.98% | 減少 |
| 13 | AGIO | Agios Pharmaceuticals INC | +1.1% | -92.61% | 減少 |
| 14 | ✓ | Foamix Pharmaceuticals LTD | +0.9% | +215.00% | 増加 |
| 15 | AMAG | Amag Pharmaceuticals INC | -1.1% | -94.92% | 減少 |
| 16 | RCKT 5 02-15-20 | Rocket Pharmaceuticals | -1.2% | -37.98% | 減少 |
| 17 | AFRM | Affirm Holdings, Inc. | -1.3% | +258.33% | 増加 |
| 18 | ✓ | Intec Pharma LTD Jerusalem | -1.5% | -73.08% | 減少 |
| 19 | ✓ | Depomed INC | -1.5% | -99.27% | 減少 |
| 20 | EWTX | Edgewise Therapeutics, Inc. | -2.1% | -15.15% | 減少 |
| 21 | ✓ | Biolinerx Ltd-spons Adr | -3.2% | — | 変化なし |
| 22 | ✓ | Amarin Corp PLC | -5% | -44.00% | 減少 |
| 23 | ✓ | Nabriva Therapeutics AG | -6.4% | -87.72% | 減少 |
| 24 | ✓ | Auris Med Hldg AG | — | EXIT | 全売却 |
| 25 | ✓ | Ophthotech Corporation | — | EXIT | 全売却 |
| 26 | ✓ | Horizon Pharma PLC | — | NEW | 新規購入 |
| 27 | GBTUSD | Global Blood Therapeutics In | — | NEW | 新規購入 |
| 28 | AKAOQ | Achaogen INC | — | EXIT | 全売却 |
| 29 | ✓ | Evoke Pharma INC | — | EXIT | 全売却 |
| 30 | MGNX | Macrogenics INC | — | NEW | 新規購入 |
| 31 | ✓ | Aquinox Pharmaceuticals INC Bc | — | NEW | 新規購入 |
| 32 | ADAPY | Adaptimmune Therapeutics-adr | — | EXIT | 全売却 |
| 33 | MODV | ModivCare Inc. | — | EXIT | 全売却 |
| 34 | GERN | Geron CORP | — | EXIT | 全売却 |
| 35 | PRTA | Prothena Corporation plc | — | NEW | 新規購入 |
| 36 | ✓ | Loxo Oncology INC | — | NEW | 新規購入 |
| 37 | SG7 | Sage Therapeutics INC | — | EXIT | 全売却 |
| 38 | ✓ | Zogenix INC | — | NEW | 新規購入 |
| 39 | CTMX | Cytomx Therapeutics INC | — | NEW | 新規購入 |
| 40 | PTIEUR | Proteostasis Therapeutics In | — | NEW | 新規購入 |
| 41 | LION | Lionsgate Studios Corp. | — | NEW | 新規購入 |
| 42 | ✓ | Ohr Pharmaceutical INC | — | EXIT | 全売却 |
| 43 | NKTREUR | Nektar Therapeutics | — | EXIT | 全売却 |
| 44 | ✓ | Cytrx CORP | — | EXIT | 全売却 |
| 45 | XOMA | XOMA Royalty Corporation | — | EXIT | 全売却 |
| 46 | RTRXEUR | Retrophin INC | — | EXIT | 全売却 |
| 47 | TGTX | Tg Therapeutics INC | — | EXIT | 全売却 |
| 48 | ✓ | Innocoll Hldgs PLC | — | NEW | 新規購入 |
| 49 | ✓ | Nivalis Therapeutics INC | — | EXIT | 全売却 |
| 50 | SUPN | Supernus Pharmaceuticals INC | — | EXIT | 全売却 |